Business Context and Reporting Period
LiqTech International, Inc. (Nevada) filed this Form 8-K on July 15, 2014, to report the entry into a Material Definitive Agreement. On this date, LiqTech International A/S, a wholly-owned Danish subsidiary, entered into a Securities Purchase Agreement to acquire 100% of the issued and outstanding capital stock of Provital Solutions A/S (the "Target").
Key Financial Metrics and Transaction Structure
The acquisition consideration consists of a mix of cash and equity, totaling approximately USD$8.4 million based on the Public Offering price:
- Cash Consideration: DKK12,600,000 (approximately USD$2,300,000).
- Equity Consideration: Shares of Common Stock valued at DKK33,600,000 (approximately USD$6,100,000).
Payment Share Escrow and Performance Milestones:
- Lock-up: One-third of the Payment Shares are subject to a six-month lock-up.
- Escrow: Two-thirds of the Payment Shares are held in escrow, released based on Target's performance:
- 2014 Milestone: Release of one-third contingent on achieving either (i) DKK65M revenue and DKK6.5M EBITDA, or (ii) DKK50M revenue and DKK10M EBITDA.
- 2015 Milestone: Release of one-third contingent on achieving either (i) DKK120M revenue and DKK12M EBITDA, or (ii) DKK80M revenue and DKK16M EBITDA.
- Catch-up Provisions: Additional releases possible if accumulated 2014-2015 targets or 2016 standalone targets are met.
The filing text does not provide specific revenue, profit, cash flow, or debt metrics for LiqTech International, Inc. itself, other than the transaction values. Audited financial statements for the Target (Provital Solutions A/S) for 2012 and 2013 are attached as Exhibit 99.1.
Material Changes and Conditions
The primary material change is the pending acquisition of Provital Solutions A/S. The transaction is subject to conditions precedent, including:
- Obtaining satisfactory financing in the Subsidiary's sole discretion.
- The Company intends to secure this financing through a Public Offering.
- Standard representations and warranties contained in the Purchase Agreement.
As part of the agreement, the Company is obligated to provide working capital support to the Target to facilitate growth and the launch of new products.
Guidance, Outlook, and Risks
Outlook: Management intends to support the Target's growth and product launches post-acquisition. The deal structure incentivizes future performance through the escrowed shares.
Risks and Contingencies:
- Financing Risk: The acquisition is contingent upon the Company successfully obtaining financing via a Public Offering.
- Performance Risk: A significant portion of the equity consideration (two-thirds) is contingent on the Target meeting specific revenue and EBITDA targets in 2014 and 2015.
- Working Capital Obligation: The Company has committed to providing working capital support, which may impact future liquidity.
Investor Verification Checklist
- Verify the terms and status of the Public Offering intended to fund the acquisition.
- Review the audited financial statements of Provital Solutions A/S (Exhibit 99.1) to assess historical performance against the 2014/2015 milestones.
- Examine the Unaudited Pro Forma Condensed Combined Financial Information (Exhibit 99.2) to understand the combined entity's projected financial position.
- Confirm the specific valuation of the Common Stock used to calculate the USD$6.1 million equity component.
- Assess the Company's current liquidity to determine its ability to fund the DKK12.6 million cash portion and future working capital obligations.